Conversely, systemic insulin resistance and inflammation induced by NAFLD may indirectly affect MYH2 expression and skeletal muscle function (42, 43).The role of MYH2 in muscle metabolism, inflammatory responses, and chronic diseases underscores its potential as a therapeutic target. This evidence concerns the gene MYH2 and Insulin resistance.